On the other hand, MYC has been reported to bind the HES6 gene promoter in the lymphoblastic leukemia HPB-ALL human cell line 63, and in aggressive human prostate cancer cells, HES6 expression is controlled by c-Myc 40. Here, MYC is linked to prostate carcinoma.